Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 17 de 17
Filtrer
1.
World J Otorhinolaryngol Head Neck Surg ; 10(2): 113-120, 2024 Jun.
Article de Anglais | MEDLINE | ID: mdl-38855290

RÉSUMÉ

Objective: This cross-sectional study aimed to determine the epidemiology of olfactory and gustatory dysfunctions related to COVID-19 in China. Methods: This study was conducted by 45 tertiary Grade-A hospitals in China. Online and offline questionnaire data were obtained from patients infected with COVID-19 between December 28, 2022, and February 21, 2023. The collected information included basic demographics, medical history, smoking and drinking history, vaccination history, changes in olfactory and gustatory functions before and after infection, and other postinfection symptoms, as well as the duration and improvement status of olfactory and gustatory disorders. Results: Complete questionnaires were obtained from 35,566 subjects. The overall incidence of olfactory and taste dysfunction was 67.75%. Being female or being a cigarette smoker increased the likelihood of developing olfactory and taste dysfunction. Having received four doses of the vaccine or having good oral health or being a alcohol drinker decreased the risk of such dysfunction. Before infection, the average olfactory and taste VAS scores were 8.41 and 8.51, respectively; after infection, they decreased to 3.69 and 4.29 and recovered to 5.83 and 6.55 by the time of the survey. The median duration of dysosmia and dysgeusia was 15 and 12 days, respectively, with 0.5% of patients having symptoms lasting for more than 28 days. The overall self-reported improvement rate was 59.16%. Recovery was higher in males, never smokers, those who received two or three vaccine doses, and those that had never experienced dental health issues, or chronic accompanying symptoms. Conclusions: The incidence of dysosmia and dysgeusia following infection with the SARS-CoV-2 virus is high in China. Incidence and prognosis are influenced by several factors, including sex, SARS-CoV-2 vaccination, history of head-facial trauma, nasal and oral health status, smoking and drinking history, and the persistence of accompanying symptoms.

2.
Hum Vaccin Immunother ; 20(1): 2315653, 2024 Dec 31.
Article de Anglais | MEDLINE | ID: mdl-38372046

RÉSUMÉ

To investigate the HPV vaccine coverage and post-vaccination adverse reactions in Gansu Province, Western China, from 2018 to 2021. Data on suspected adverse reactions to HPV vaccines were collected from the Chinese Vaccine Adverse Event Following Immunization (AEFI). Estimate the incidence rates of Common Adverse Reaction and Rare Adverse Reaction. HPV vaccine coverage among females in different age groups was calculated using data from the Gansu Provincial Immunization Information Platform. The first-dose HPV vaccine coverage rate among females aged 9 to 45 was 2.02%, with the lowest rate of less than 1% observed in females aged 9 to 14. From 2018 to 2021, the incidence rates of Common Adverse Reaction and Rare Adverse Reaction reported in females after HPV vaccination were 11.82 and 0.39 per 100,000 doses, respectively. Common Adverse Reaction included fever (5.52 per 100,000 doses), local redness and swelling (3.33 per 100,000 doses), fatigue (3.15 per 100,000 doses), headache (2.76 per 100,000 doses), as well as local induration and nausea/vomiting (1.97 per 100,000 doses). Adverse reactions mainly occurred within 1 day after vaccination, followed by 1 to 3 days after vaccination. The HPV vaccine coverage rate among females aged 9 to 14 in Gansu Province is remarkably low, and there is an urgent need to enhance vaccine coverage. From 2018 to 2021, the incidence of Adverse reaction Following Immunization HPV vaccination fell within the expected range, indicating the vaccine's safety profile.


Sujet(s)
Infections à papillomavirus , Vaccins contre les papillomavirus , Femelle , Humains , Vaccins contre les papillomavirus/effets indésirables , Infections à papillomavirus/prévention et contrôle , Infections à papillomavirus/étiologie , Vaccination/effets indésirables , Immunisation , Chine/épidémiologie
4.
Anal Bioanal Chem ; 408(7): 1975-81, 2016 Mar.
Article de Anglais | MEDLINE | ID: mdl-26558763

RÉSUMÉ

A high-performance liquid chromatography coupled to Fourier transform ion cyclotron resonance mass spectrometry (HPLC-FT-ICR MS) method was developed to study the in vivo metabolism of salidroside for the first time. Plasma, urine, bile, and feces samples were collected from male rats after a single intragastric gavage of salidroside at a dose of 50 mg/kg. Besides the parent drug, a total of seven metabolites (three phase I and four phase II metabolites) were detected and tentatively identified by comparing their mass spectrometry profiles with those of salidroside. Results indicated that metabolic pathways of salidroside in male rats included hydroxylation, dehydrogenation, glucuronidation, and sulfate conjugation. Among them, glucuronidation and sulfate conjugation were the major metabolic reactions. And most important, the detection of the sulfation metabolite of p-tyrosol provides a clue for whether the deglycosylation of salidroside occurs in vivo after intragastric gavage. In summary, results obtained in this study may contribute to the better understanding of the safety and mechanism of action of salidroside.


Sujet(s)
Chromatographie en phase liquide à haute performance/méthodes , Glucosides/métabolisme , Spectrométrie de masse/méthodes , Voies et réseaux métaboliques , Phénols/métabolisme , Animaux , Antioxydants/analyse , Antioxydants/métabolisme , Antioxydants/pharmacocinétique , Bile/composition chimique , Bile/métabolisme , Cyclotrons , Fèces/composition chimique , Analyse de Fourier , Glucosides/analyse , Glucosides/sang , Glucosides/urine , Mâle , Métabolome , Phénols/analyse , Phénols/sang , Phénols/urine , Rats , Rat Sprague-Dawley , Rhodiola/composition chimique
5.
Nat Prod Res ; 30(3): 358-61, 2016.
Article de Anglais | MEDLINE | ID: mdl-26190288

RÉSUMÉ

Two new isoaurones derivatives were obtained from Callistephus chinensis flower. Their structures were elucidated on the basis of extensive spectroscopic analyses. Both of the new compounds were evaluated cytotoxic activity. Phytochemical investigation of Callistephus chinensis flower led to the isolation of two new isoaurones derivatives (Z)-4',4,10-trihydroxy-siamaurone (1) and (E)-4',4,10-trihydroxy-siamaurone (2). The structures of these new compounds were identified by the interpretation of spectroscopic data (mainly 1D and 2D NMR) and by comparison with data reported in the literature. Both of the new compounds were evaluated for their cytotoxicity.


Sujet(s)
Asteraceae/composition chimique , Benzofuranes/composition chimique , Fleurs/composition chimique , Benzofuranes/isolement et purification , Benzofuranes/pharmacologie , Lignée cellulaire tumorale/effets des médicaments et des substances chimiques , Chine , Tests de criblage d'agents antitumoraux/méthodes , Humains , Concentration inhibitrice 50 , Spectroscopie par résonance magnétique , Structure moléculaire
6.
Steroids ; 104: 276-83, 2015 Dec.
Article de Anglais | MEDLINE | ID: mdl-26514740

RÉSUMÉ

Gypensapogenin H (GH) is a novel dammarane-type triterpenes obtained from hydrolyzate of total saponins from Gynostemma pentaphyllum and its anti-tumor activity has been studied in previous work. In this study, we report the effects of this compound on human prostate cancer cells (DU145 and 22RV-1). It significantly inhibited proliferation, decreased survival, led to G1 cell cycle arrest and induced apoptosis in both cell lines, while having lesser effect on the growth of normal human gastric mucosa cells (GES-1), embryonic kidney cells (HEK293) and lung fibroblast cells (MRC5). Consistent with these phenotypes, we observed decreased expression of the cell cycle-related proteins cyclinD1, and CDK4, and increased expression of p21 in GH-treated cells. Besides, the anti-apoptotic Bcl-2 protein decreased in a dose-dependent manner, while Bax, cleaved caspase-3 and -9 increased upon GH treatment. Taken together, these results indicated GH exerted promising anticancer activity, and may represent a potential agent for the treatment of prostate cancer.


Sujet(s)
Antinéoplasiques d'origine végétale/pharmacologie , Apoptose/effets des médicaments et des substances chimiques , Points de contrôle du cycle cellulaire/effets des médicaments et des substances chimiques , Gynostemma/composition chimique , Tumeurs de la prostate/anatomopathologie , Saponines/composition chimique , Triterpènes/pharmacologie , Antinéoplasiques d'origine végétale/composition chimique , Antinéoplasiques d'origine végétale/isolement et purification , Lignée cellulaire , Prolifération cellulaire/effets des médicaments et des substances chimiques , Relation dose-effet des médicaments , Tests de criblage d'agents antitumoraux , Cellules HEK293 , Humains , Mâle , Conformation moléculaire , Tumeurs de la prostate/traitement médicamenteux , Saponines/isolement et purification , Saponines/pharmacologie , Relation structure-activité , Triterpènes/composition chimique , Triterpènes/isolement et purification ,
7.
J Ethnopharmacol ; 172: 402-9, 2015 Aug 22.
Article de Anglais | MEDLINE | ID: mdl-26163196

RÉSUMÉ

ETHNOPHARMACOLOGICAL RELEVANCE: Zhi-Zi-Da-Huang decoction (ZZDHD), a classic traditional Chinese medicine (TCM) formula composed of four herbal medicines, has been widely used to treat various hepatobiliary disorders for a long time in China. However, the pharmacological effect of ZZDHD on liver injury with cholestasis is unrevealed. AIM OF THE STUDY: To investigate the hepatoprotective effect of ZZDHD against α-naphthylisothiocyanate (ANIT)-induced liver injury with cholestasis in rats. MATERIALS AND METHODS: The rats were intragastrically (i.g.) given ZZDHD at doses of 1, 2 and 4 g/kg (crude drug/body weight) once a day for seven days and treated with ANIT (75 mg/kg via i.g.) to cause liver injury at 12h after the fifth administration. The serum levels of alanine aminotransferase (ALT), aspartate aminotransferase (AST), alkaline phosphatase (ALP), γ-glutamyltranspeptidase (γ-GTP), total bilirubin (TBIL), direct bilirubin (DBIL) and total bile acid (TBA), as well as bile flow were measured at 48 h after ANIT treatment to evaluate the protective effect of ZZDHD. Moreover, the possible protective mechanisms were elucidated by assays of liver enzyme activities and component contents including malondialdehyde (MDA), myeloperoxidase (MPO), lipid peroxide (LPO), superoxide dismutase (SOD), glutathione peroxidase (GPx), and catalase (CAT). The biochemical observations were supplemented by histopathological examination. Ultra fast liquid chromatography-mass spectrometry (UFLC-MS) was used for the phytochemical analysis of ZZDHD. RESULTS: The high dose (4 g/kg) and middle dose (2g/kg) of ZZDHD exhibited significant and dose-dependent protective effect on ANIT-induced liver injury with cholestasis by reversing the changes in bile flow, the serum and hepatic enzymes, and histopathology of the liver tissue. Meanwhile, it was found that the low dose (1g/kg) of ZZDHD did not improve the biochemical indexes except serum TBIL, DBIL and TBA, which showed little protective effect. Phytochemical analysis revealed the presence of sixteen compounds in ZZDHD. CONCLUSIONS: This study indicates that ZZDHD exerted a hepatoprotective effect on ANIT-induced liver injury with cholestasis in rats, and the mechanism of this activity is possibly related to its antioxidant properties.


Sujet(s)
Antioxydants/pharmacologie , Cholestase/prévention et contrôle , Médicaments issus de plantes chinoises/pharmacologie , Maladies du foie/prévention et contrôle , 1-Naphtyl-isothiocyanate/toxicité , Maladie aigüe , Animaux , Antioxydants/administration et posologie , Cholestase/anatomopathologie , Chromatographie en phase liquide à haute performance , Modèles animaux de maladie humaine , Relation dose-effet des médicaments , Médicaments issus de plantes chinoises/administration et posologie , Maladies du foie/anatomopathologie , Mâle , Spectrométrie de masse , Rats , Rat Sprague-Dawley
8.
Bioorg Med Chem Lett ; 25(16): 3095-9, 2015 Aug 15.
Article de Anglais | MEDLINE | ID: mdl-26099540

RÉSUMÉ

In this study, five novel triterpenes were isolated from hydrolyzate of total saponins from Gynostemma pentaphyllum and identified as gypensapogenin H (1), gypensapogenin I (2), gypensapogenin L (3), gypensapogenin J (4) and gypensapogenin K (5), three of which (1-3) possess unprecedented ring A. All the isolated compounds were evaluated for cytotoxic activities in five cell lines and all the tested compounds showed significant anti-cancer activities against a series of human cancer cell lines, while having much weaker effect on the growth of normal cell. Among them, compound 1 showed strong inhibition toward MCF-7 human breast cancer cells (IC50 values 6.85 µM). Further mechanistic study demonstrated that compound 1 significantly induced MCF-7 cell apoptosis. Our results indicated that compound 1 may be a promising lead agent for further study.


Sujet(s)
Gynostemma/composition chimique , Saponines/composition chimique , Triterpènes/composition chimique , Antinéoplasiques d'origine végétale/composition chimique , Antinéoplasiques d'origine végétale/isolement et purification , Antinéoplasiques d'origine végétale/pharmacologie , Apoptose/effets des médicaments et des substances chimiques , Lignée cellulaire tumorale , Gynostemma/métabolisme , Humains , Cellules MCF-7 , Spectroscopie par résonance magnétique , Conformation moléculaire , Triterpènes/isolement et purification , Triterpènes/pharmacologie ,
9.
Bioorg Med Chem Lett ; 24(23): 5390-4, 2014 Dec 01.
Article de Anglais | MEDLINE | ID: mdl-25453794

RÉSUMÉ

In the current work, 12 novel 25-hydroxyprotopanaxadiol (25-OH-PPD) derivatives were synthesized by reacting with chloroacetyl chloride. And their in vitro antitumor activities were evaluated on six human tumor cell lines by MTT assay. The results demonstrated that, as compared with 25-OH-PPD, compounds 4, 6 and 7 exhibited higher cytotoxic activity on all tested cell lines. Of them, compound 4 showed strongly inhibition against MCF-7, HCT-116 and Lovo cells with IC50 values of 1.7, 1.6 and 2.1 µM, respectively. The IC50 values of compound 6 against HCT-116 and 7 against MCF-7 were the lowest (1.2 and 1.6 µM, respectively). It was also noted that compound 4 showed a 20- to 100-fold greater growth inhibition than ginsenoside-Rg3 (an anti-cancer regular drug in China). In conclusion, the data revealed that compounds 4, 6 and 7 were potential candidates for anti-tumor treatment and may be useful for the development of novel antiproliferative agents.


Sujet(s)
Acétates/métabolisme , Ginsénosides/métabolisme , Tumeurs/traitement médicamenteux , Panax/composition chimique , Acétates/composition chimique , Antinéoplasiques/pharmacologie , Produits biologiques , Lignée cellulaire tumorale , Prolifération cellulaire , Ginsénosides/composition chimique , Humains , Structure moléculaire , Relation structure-activité
10.
Zhonghua Liu Xing Bing Xue Za Zhi ; 34(1): 24-7, 2013 Jan.
Article de Chinois | MEDLINE | ID: mdl-23648244

RÉSUMÉ

OBJECTIVE: To evaluate the safety of both domestic live attenuated and inactivated hepatitis A vaccines, and to provide reference for emergent vaccination after hepatitis A outbreaks. METHODS: 493 children aged 6 - 9 with negative antibody to HAV (produced by Abbott) were randomly divided into four groups as vaccinated with domestic live attenuated hepatitis A vaccine (Group A), domestic inactivated hepatitis A vaccine (Group B), imported inactivated hepatitis A vaccine (Group C) and hepatitis B vaccine (Group D) respectively. Adverse events following the immunization were observed 30 minutes, 24, 48 and 72 hours after the vaccination, under double-blind method. RESULTS: The main AEFIs were: fever, local pain and scleroma but no other severe AEFIs were observed. The rates of AEFIs were 13.95% in Group A, 15.25% in group B, 16.80% in group C and 25.62% in group D, with no statistical differences between these groups (χ(2) = 6.953, P > 0.05). 2 weeks after the vaccination, the positive conversion rates of domestic live attenuated hepatitis A vaccine and domestic inactivated hepatitis A vaccine were 85.0% and 94.59% respectively. The rate of domestic inactivated hepatitis A vaccine reached 100% at 4 weeks after the vaccination. The antibody levels of HAV-IgG of Group A and B in 2, 4 and 12 weeks of vaccination and of Group C were higher than that of Group D. After 12 weeks of vaccination, the antibody level of group B became higher than it was Group C. CONCLUSION: There were no differences on safety among domestic live attenuated hepatitis A vaccine, domestic inactivated hepatitis A vaccine or imported inactivated hepatitis A vaccine under routine or emergency vaccination. All the vaccines showed satisfactory effects.


Sujet(s)
Vaccins anti-hépatite A , Hépatite A/prévention et contrôle , Enfant , Chine , Méthode en double aveugle , Femelle , Vaccins anti-hépatite A/effets indésirables , Vaccins anti-hépatite A/immunologie , Humains , Immunisation , Mâle , Sécurité , Vaccins atténués/effets indésirables , Vaccins atténués/immunologie , Vaccins inactivés/effets indésirables , Vaccins inactivés/immunologie
11.
Bioorg Med Chem Lett ; 23(1): 297-300, 2013 Jan 01.
Article de Anglais | MEDLINE | ID: mdl-23177789

RÉSUMÉ

Protein tyrosine phosphatase 1B (PTP1B) is an important factor in non-insulin-dependent diabetes mellitus (type-2 diabetes), and a promising target for treatment of diabetes and obesity. Therefore, the aim of this study is to investigate the inhibitory activities of constituents (three new together with twelve known triterpenes compounds) isolated from the hydrolyzate of total saponins from Gynostemma pentaphyllum. Their structures were accomplished mainly base on the spectroscopic methods, and then were further confirmed by X-ray crystal diffraction. All the compounds were evaluated for inhibitory activity against PTP1B. Current data suggested that the compounds 1, 3, 12, 13 and 14 were considered to be potential as antidiabetic agents, in which they could significantly inhibit the PTP1B enzyme activity in a dose-dependent manner.


Sujet(s)
Gynostemma/composition chimique , Protein Tyrosine Phosphatase, Non-Receptor Type 1/antagonistes et inhibiteurs , Saponines/composition chimique , Triterpènes/composition chimique , Cristallographie aux rayons X , Hydrolyse , Spectroscopie par résonance magnétique , Conformation moléculaire , Liaison aux protéines , Protein Tyrosine Phosphatase, Non-Receptor Type 1/métabolisme , Triterpènes/métabolisme ,
12.
Zhonghua Yu Fang Yi Xue Za Zhi ; 47(10): 924-7, 2013 Oct.
Article de Chinois | MEDLINE | ID: mdl-24378133

RÉSUMÉ

OBJECTIVE: To learn the characteristics of pathogen spectrum of Encephalitis /Meningitis in northwestern area of China. METHODS: Between January 1st 2009 and March 31st 2011, a total of 569 patients with clinical symptoms of Encephalitis/Meningitis were selected from the hospitals in Gansu, Qinghai,Inner Mongolia and Xinjiang province. 1514 samples of specimen were collected from the 515 patients, to detect the IgM of Japanese encephalitis virus (JEV), enterovirus (EV, including Coxsackie virus, ECHO virus and enterovirus 71), Mumps virus, Herpes simplex virus (HSV) in blood and cerebrospinal fluid. Meanwhile, Neisseria meningitis (Nm), Haemophilus influenzae Type B (Hib), Staphylococcus, Streptococcus pneumonia, Streptococcus Suis, E. Coli and Cryptococci were also identified. The detection results were analyzed by different region, time and age range. RESULTS: Pathogenic bacteria were identified in the specimen from 16 patients, with the rate at 3.65%, of which the dominant ones were Streptococcus pneumonia (7 patients, 43.75%). Virus were identified in the specimen from 132 patients, with the rate at 27.05%, of which the dominant types were EV and HSV, accounting for 33.33% (44 cases) and 31.82% (42 cases) respectively. The detection rate of virus showed a significant seasonal trend, with the peak appearing between June and November each year. The peak of EV detection was between July and September, with 24 cases detected out; the peak of HSV was between June and August (11 cases detected out); mumps virus was mainly found between July and December (25 cases). There was no significant time-distribution found in the detection of bacteria. The EV and HSV were mainly distributed in Gansu and Qinghai province (70 cases) ;most of mumps virus were found in Gansu province (24 cases);and JEV were only found in Gansu province (20 cases). The viral pathogen spectrum was identified in all ages, and the EV and mumps virus were mainly found in children aged 0-14 years old (42 and 17 cases respectively) ; JEV were identified in people over 15 years old, with 13 detected out of the 20 patients. CONCLUSION: The main pathogen of acute encephalitis and meningitis in northwestern area of China was virus, and the main pathogens of encephalitis and meningitis in children under 15 years were Herpes simplex virus and Mumps virus.


Sujet(s)
Encéphalite/microbiologie , Encéphalite/virologie , Méningite/microbiologie , Méningite/virologie , Adolescent , Adulte , Anticorps antiviraux/sang , Anticorps antiviraux/liquide cérébrospinal , Enfant , Enfant d'âge préscolaire , Chine/épidémiologie , Encéphalite/épidémiologie , Virus de l'encéphalite japonaise (espèce)/isolement et purification , Enterovirus/isolement et purification , Femelle , Humains , Immunoglobuline M/sang , Immunoglobuline M/liquide cérébrospinal , Nourrisson , Nouveau-né , Mâle , Méningite/épidémiologie , Adulte d'âge moyen , Virus des oreillons/isolement et purification , Simplexvirus/isolement et purification , Jeune adulte
13.
J Tradit Chin Med ; 32(1): 125-8, 2012 Mar.
Article de Anglais | MEDLINE | ID: mdl-22594116

RÉSUMÉ

OBJECTIVE: To analyze the cost effect of surrounding acupuncture plus electric acupuncture, cotton-sheet moxibustion, puncturing with red-hot needles, tapping plus cupping on herpes zoster. METHODS: Five hundred patients with herpes zoster were randomly divided into group A (surrounding acupuncture plus electric acupuncture), group B (cotton-sheet moxibustion), group C (puncturing with red-hot needles), group D (tapping plus cupping), and group E (Western medicine). The treatment was carried out twice a day in group E and once a day in the other four groups. The curative effect was observed on the 10th day of treatment; the cost was calculated for the five therapies, and the cost-effect ratio (C/E) and increment ratio (delta C/delta E) were analyzed. RESULTS: After the 10-day treatment, there was no statistical difference (P > 0.05) in the curative effect among the five groups. Pain being alleviated one day faster than in group E amounted to a saving of RMB 21.90 yuan in group A, a saving of RMB 21.87 yuan in group B, a saving of RMB 26.00 yuan in group C, and a saving of RMB 20.23 yuan in group D. Compared with group C, the values of delta C/delta E were RMB 1.55, 2.81, and 0.21 yuan in groups A, B, and D, respectively. CONCLUSIONS: The curative effect in groups A, B, C, and D was similar to that in group E, but the C/E was better than in group E.


Sujet(s)
Thérapie par acupuncture/économie , Zona/thérapie , Moxibustion/économie , Gestion de la douleur/économie , Thérapie par acupuncture/méthodes , Adulte , Sujet âgé , Femelle , Zona/économie , Humains , Mâle , Adulte d'âge moyen , Moxibustion/méthodes , Gestion de la douleur/méthodes
14.
Zhonghua Yu Fang Yi Xue Za Zhi ; 46(12): 1099-102, 2012 Dec.
Article de Chinois | MEDLINE | ID: mdl-23363967

RÉSUMÉ

OBJECTIVE: To understand the epidemiological characteristics and the main clinical symptoms of viral encephalitis in Gansu. METHODS: A total of 322 viral encephalitis patients were recruited from province sentinel hospitals in Gansu province from 2009 to 2011, and their basic information were collected as well as their serum samples and cerebrospinal fluid samples. 296 out of the 322 cases were qualified for our study. Based on the patients' epidemiological characteristics and clinical features, we determined the detection of the virus types (at least one kind of virus detection was carried out for each case). ELISA was applied to test the IgM antibody of Japanese encephalitis (JE) virus (JEV), enterovirus (EV: including Coxsackie virus, echovirus, enterovirus 71), mumps virus and herpes simplex virus (HSV) in cerebrospinal fluid and serum specimen. The difference of positive detected rate between types of virus, among patients from different regions, time, or at different ages, as well as the different clinical symptoms between JE patients and other viral encephalitis patients, were analyzed and compared. RESULTS: The positive detected rate of virus in the 296 patients was 27.03% (80/296); the positive rate of JEV, EV, mumps virus, HSV detected was separately 7.53% (22/292), 8.75% (23/263), 13.84% (22/159) and 15.09% (40/265), and the difference was statistically significant (χ(2) = 10.849, P < 0.05). 90.91% (20/22) of the JEV positive cases were distributed in Tianshui, Longnan and Pingliang, and 95.45% (21/22) patients were infected from July to September. All the 23 EV detected positive patients were infected from April to December, while the ages of patients ranged from 1 to 44 years old. Mumps virus, HSV testing positive cases had onset every month. Logistic regression analysis showed that the patients who had the symptoms as disturbance of consciousness (OR = 15.487, 95%CI: 2.266 - 105.852), somnolence (OR = 11.659, 95%CI: 1.783 - 76.242), convulsions (OR = 11.062, 95%CI: 1.687 - 72.530) were more likely to infect JEV. CONCLUSION: HSV was the principal pathogen of viral encephalitis in Gansu. An obvious central tendency in the regional and time distribution was found in JEV infection; and the clinical symptoms of JE patients were more severe.


Sujet(s)
Encéphalite virale/diagnostic , Encéphalite virale/épidémiologie , Adolescent , Adulte , Anticorps antiviraux/sang , Anticorps antiviraux/liquide cérébrospinal , Enfant , Enfant d'âge préscolaire , Chine/épidémiologie , Virus de l'encéphalite japonaise (espèce) , Encéphalite virale/virologie , Enterovirus , Test ELISA , Femelle , Humains , Immunoglobuline M/sang , Immunoglobuline M/liquide cérébrospinal , Nourrisson , Mâle , Virus des oreillons , ARN viral/sang , ARN viral/liquide cérébrospinal , Simplexvirus , Jeune adulte
15.
Zhongguo Yi Miao He Mian Yi ; 15(2): 119-22, 2009 Apr.
Article de Chinois | MEDLINE | ID: mdl-20077655

RÉSUMÉ

OBJECTIVE: To analyse the incidence character of varicella in Shandong, Gansu and Hunan provinces in 2007. METHOD: One township of rural area and one community of urban area were selected from Shandong, Gansu and Hunan each province for sampling. 34578 children were sampled and 1213 clinical diagnostic cases were confirmed. RESULT: The incidence of 0-14 ys was 1836.72/100,000 and the estimated incidence of entire population was 357.95/100,000. The peak age of incidence was 5-9 age group children. CONCLUSION: The incidence of varicella in China was high and the incidence was different between areas or ages.


Sujet(s)
Varicelle/épidémiologie , Adolescent , Répartition par âge , Varicelle/virologie , Enfant , Enfant d'âge préscolaire , Chine/épidémiologie , Femelle , Humains , Incidence , Nourrisson , Nouveau-né , Mâle
16.
Zhongguo Yi Miao He Mian Yi ; 15(2): 123-6, 2009 Apr.
Article de Chinois | MEDLINE | ID: mdl-20077656

RÉSUMÉ

OBJECTIVE: To analyse the economic burden of outpatient with varicella in China in 2007. METHODS: In three provinces, the sample were places are stratified by economic condition in district, county and township level. 811 outpatient cases were sampled and analysized. RESULTS: The cost of outpatient was 493.66 RMB per case, including direct expenses 219.52 RMB and indirect expenses 274.14 RMB per case. The total cost of outpatient varicella in China was 2.3 billion RMB in 2007. CONCLUSIONS: The disease burden was heavy in China.


Sujet(s)
Varicelle/économie , Coûts des soins de santé , Dépenses de santé , Patients en consultation externe , Varicelle/épidémiologie , Enfant , Enfant d'âge préscolaire , Chine/épidémiologie , Femelle , Humains , Mâle
17.
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi ; 24(4): 373-4, 377, 2008 Apr.
Article de Chinois | MEDLINE | ID: mdl-18394348

RÉSUMÉ

AIM: To investigate the expression of LAIR-1 in patients with tumors and the function of LAIR-1 in anticancer immunity. METHODS: A sandwich ELISA was employed to detect the serum sLAIR-1 from tumor patients and healthy individuals. The expression of LAIR-1 in CD4+ T cells, CD8+ T cells, NK cells and B cells isolated from the peripheral blood of cancer patients was examined by fluorescence staining and flow cytometry. RESULTS: The level of serum sLAIR-1 in tumor patients was higher than that in healthy individuals [4.6+/-3.2 microg/L vs 3.9+/-3.0 microg/L, P<0.05]. NK cells, CD4+ T cells and CD8+ T cells expressed the up-regulated LAIR-1. The ratio of CD4/CD8 in lung cancer patients decreased significantly while the percentage of B cells in cancer patients increased greatly compared with healthy individuals. CONCLUSION: The expression of LAIR-1 is up-regulated in tumor patients, which may contribute to cancer immune escape.


Sujet(s)
Agranulocytes/métabolisme , Tumeurs/sang , Récepteurs immunologiques/sang , Récepteurs immunologiques/métabolisme , Adolescent , Adulte , Lymphocytes B/métabolisme , Lymphocytes T CD4+/métabolisme , Lymphocytes T CD8+/métabolisme , Femelle , Cytométrie en flux , Humains , Cellules tueuses naturelles/métabolisme , Mâle , Adulte d'âge moyen , Jeune adulte
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE
...